Pegaspargase in the Treatment of Acute Lymphoblastic Leukemia: A CMA Model Demonstrates Its Economic Benefit for the Italian National Health System

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.1402
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Molecular Emergence of Acute Myeloid Leukemia During Treatment for Acute Lymphoblastic Leukemia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2000English

Novel Immunotherapeutic Approaches for the Treatment of Acute Leukemia (Myeloid and Lymphoblastic)

Therapeutic Advances in Hematology
Hematology
2015English

Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Targeting the PIM Protein Kinases for the Treatment of a T-Cell Acute Lymphoblastic Leukemia Subset

Oncotarget
Oncology
2017English

Acute Lymphoblastic Leukemia

2016English

Acute Lymphoblastic Leukemia

2020English

Acute Lymphoblastic Leukemia

English

Acute Lymphoblastic Leukemia

2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy